Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FPRF5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,450
Award facts
- Contract value 100% obligated
- $98,449.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $98,449.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 ml vials. This firm fixed-price delivery order, issued on August 26, 2025, is scheduled for ultimate completion by September 17, 2025, with performance to take place in Park Ridge, Illinois. The contract carries no set-aside designation, allowing the vendor to compete on a full and open basis despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499.9 million and valid through November 2026. That umbrella contract enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support military health facilities worldwide. Keytruda, an oncology treatment, aligns with the broader portfolio of specialty medications and pharmaceutical products the vendor supplies to Department of Defense healthcare systems as a critical supplier in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FPRF5?
SPE2DB25FPRF5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FPRF5 worth?
The government has obligated $98,450 on SPE2DB25FPRF5.
Is contract SPE2DB25FPRF5 an order under another contract?
Yes. SPE2DB25FPRF5 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRF5 competed?
The extent of competition for SPE2DB25FPRF5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award